New cancer drug CRB-701 targets Nectin-4 in advanced tumors
Disease control
Recruiting now
This study tests a drug called CRB-701, which is designed to find and attack cancer cells that have a protein called Nectin-4 on their surface. The trial includes 348 adults with advanced solid tumors that have not responded to standard treatments. Researchers aim to find a safe …
Phase: PHASE1, PHASE2 • Sponsor: Corbus Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC